Explore this issue:February 2011
SCOTTSDALE—The system of clinical cancer research, including that of head and neck cancer, is in need of an overhaul, but steps are being taken that might lead to more efficient work and will hopefully mean more medical breakthroughs, said David Schuller, MD, the chair in cancer research at the Ohio State University College of Medicine in Columbus, at the Triological Society’s Combined Sections Meeting, held here on Jan. 27.
“It truly is an inefficient process,” said Dr. Schuller, a guest speaker at the meeting. “There are a lot of delays. There is really not much in the way of formal prioritization.”
Federal funding has been stagnant for the past several years, stuck at about $160 million a year, he said. Additionally, he said, there is “extensive, if not excessive, oversight of the process.”